These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Neutrophil-lymphocyte ratio is a predictor of saphenous vein graft patency in patients undergoing coronary artery bypass surgery. Balta S; Demirkol S; Kurt O; Akhan M; Akgul EO; Kucuk U Clin Appl Thromb Hemost; 2014 Mar; 20(2):219-20. PubMed ID: 23899440 [No Abstract] [Full Text] [Related]
16. Duration after coronary artery bypass graft surgery and saphenous vein graft disease. Eyüboğlu M; Koyuncu İ Anatol J Cardiol; 2015; 15(12):1035. PubMed ID: 26663230 [No Abstract] [Full Text] [Related]
17. Endothelin-1, endothelin receptor antagonists, and vein graft occlusion in coronary artery bypass surgery: 20 years on and still no journey from bench to bedside. Dashwood MR; Loesch A Can J Physiol Pharmacol; 2020 Sep; 98(9):570-578. PubMed ID: 32343914 [TBL] [Abstract][Full Text] [Related]
19. Vessel diameter should be taken into account in saphenous stenting. Lozano I; Rondan J; Avanzas P EuroIntervention; 2010 Apr; 5(8):991-3. PubMed ID: 20542787 [No Abstract] [Full Text] [Related]
20. Advances in surgical treatment of acute and chronic coronary artery disease. Cohn WE Tex Heart Inst J; 2010; 37(3):328-30. PubMed ID: 20548814 [No Abstract] [Full Text] [Related] [Next] [New Search]